Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2015

01-07-2015 | Letter to the Editor

Letter to the Editor Re: Bundred et al. “Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer”

Authors: Leigh C. Ward, Sharon L. Kilbreath, Elizabeth Dylke

Published in: Breast Cancer Research and Treatment | Issue 1/2015

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Hayes S, Cornish B, Newman B (2005) Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up. Breast Cancer Res Treat 89:221–226CrossRefPubMed Hayes S, Cornish B, Newman B (2005) Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up. Breast Cancer Res Treat 89:221–226CrossRefPubMed
2.
go back to reference Czerniec SA, Ward LC, Lee MJ, Refshauge KM, Beith J, Kilbreath SL (2011) Segmental measurement of breast cancer related arm lymphedema using perometry and bioimpedance spectroscopy. Support Care Cancer 19:703–710CrossRefPubMed Czerniec SA, Ward LC, Lee MJ, Refshauge KM, Beith J, Kilbreath SL (2011) Segmental measurement of breast cancer related arm lymphedema using perometry and bioimpedance spectroscopy. Support Care Cancer 19:703–710CrossRefPubMed
3.
go back to reference Fu MR, Cleland CM, Guth AA, Kayal M, Haber J, Cartwright F, Kleinman R, Kang Y, Scagliola J, Axelrod D (2013) L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity. Lymphology 46:85–96PubMedPubMedCentral Fu MR, Cleland CM, Guth AA, Kayal M, Haber J, Cartwright F, Kleinman R, Kang Y, Scagliola J, Axelrod D (2013) L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity. Lymphology 46:85–96PubMedPubMedCentral
Metadata
Title
Letter to the Editor Re: Bundred et al. “Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer”
Authors
Leigh C. Ward
Sharon L. Kilbreath
Elizabeth Dylke
Publication date
01-07-2015
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2015
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-015-3404-5

Other articles of this Issue 1/2015

Breast Cancer Research and Treatment 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine